Verapamil is a non-dihydropyridine calcium channel blocker primarily used in the treatment of hypertension, angina pectoris, and certain cardiac arrhythmias. By inhibiting calcium influx into cardiac and… Read more




























Verapamil is a non-dihydropyridine calcium channel blocker primarily used in the treatment of hypertension, angina pectoris, and certain cardiac arrhythmias. By inhibiting calcium influx into cardiac and vascular smooth muscle cells, this medication effectively lowers blood pressure and manages heart rate. In analytical chemistry, reference standards for Verapamil and its related compounds are essential for maintaining rigorous quality control and regulatory compliance. This category provides highly characterized materials, including pharmacopeial and non-pharmacopeial impurities, degradation products, and metabolites such as norverapamil. Laboratories utilize these reference standards for comprehensive impurity profiling, method validation, and stability studies, ensuring that analytical methods remain accurate and reliable. Additionally, stable isotope labelled compounds are available to serve as internal standards in mass spectrometry-based assays. These materials support adherence to international quality guidelines by enabling the precise identification and quantification of impurities throughout the pharmaceutical development lifecycle.